Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China

Jian Li, Jun Zhang, Yanqiao Zhang, Haibo Qiu, Yanbing Zhou, Yongjian Zhou, Xinhua Zhang, Ye Zhou, Yuping Zhu, Yong Li, Ming Wang, Kuntang Shen, Kaixiong Tao, Xin Wu, Haijiang Wang, Bo Zhang, Jiayu Ling, Yingjiang Ye, Xingye Wu, Hongyan Qu, Yue Ma, Xuelong Jiao, Hualong Zheng, Jiejie Jin, Zhuo Liu, Ming Tan, Yong Fang, Peng Zhāng, Nan Zhang, Lei Cheng, Zhaolun Cai, Bin Liang, Zhangyan Peng, Zhao Huang, Juan Dong, Lin Shen